REVA Medical LLC

[REVA Medical LLC @RevaMedicalLLC]

https://t.co/1xHTXegudA

[REVA Medical LLC @RevaMedicalLLC]

Congratulations to Dr. Montero-Baker and his team at HOPE Vascular & Podiatry for enrolling their first patient in the MOTIV BTK trial!

[REVA Medical LLC @RevaMedicalLLC]

REVA would like to congratulate Dr. Ansari  (@macansari) and the Team at Texas Tech for leading the US single center total enrollment in the MOTIV BTK Trial for the month of November. Dr. Ansari's team enrolled 3 new patients in the trial with excellent acute results.

[REVA Medical LLC @RevaMedicalLLC]

REVA would like to congratulate PD Dr. Andrej Schmidt and the team at University-Clinic Leipzig for the successful MOTIV Peripheral Vascular Bioresorbable BTK Scaffold case that was performed during a Live-Case session at the LINC conference this past week.

[REVA Medical LLC @RevaMedicalLLC]

REVA would like to congratulate @MacAnsari and the team at @TexasTech University on the enrollment of their first patient in the MOTIV Randomized Controlled Below The Knee Trial. We are proud to be able to work with such a dedicated team.

[REVA Medical LLC @RevaMedicalLLC]

REVA Medical is dedicated to the restoration of patient health by developing #bioresorbable biomaterials and implantable medical devices. Learn more about our bioresorbable scaffolds for the treatment of #peripheralarterydisease and how we are on the leading edge of MedTech.

[ᗰIGᑌEᒪ ᗰOᑎTEᖇO-ᗷᗩKEᖇ @monteromiguel]

📣🤓Actively enrolling for the @revamedicalinc RCT MOTIV study at #HOPE - reabsorbable sirolimus eluding scaffold vs PTA in #CLTI patients. @thetoedoctor @Vascupedia_com @hendolat @WayToMy_Heart #MedTwitter